Company profile: Biosensia
1.1 - Company Overview
Company description
- Provider of point-of-care in-vitro diagnostics platforms. Offers RapiPlex, a rapid, multiplexing POC IVD platform available for licensing, enabling access to a broad range of diagnostic applications and used with a variety of common biological sample types.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Biosensia
Lucy Therapeutics
HQ: United States
Website
- Description: Provider of mitochondrial-based small molecule therapies targeting mitochondrial dysfunction to treat complex diseases with a focus on neurological disorders; diagnostic biomarkers for disease diagnosis and progression monitoring; lead programs in Parkinson's disease and Rett syndrome; and early discovery efforts for undisclosed targets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lucy Therapeutics company profile →
LEAP Technologies
HQ: Australia
Website
- Description: Provider of micro dispensing, PAL accessories, support, and repair services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LEAP Technologies company profile →
Cold Chain Technologies
HQ: United States
Website
- Description: Provider of thermal packaging solutions protecting temperature-sensitive products for pharmaceutical, life sciences, and food services, including insulated parcel and pallet shippers, thermal cargo blankets, single-use systems (CCT Advanced SU48), reusable program management, smart digital solutions, logistics management, thermal packaging design, thermal modeling, temperature profile analysis, and an online solution selector.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cold Chain Technologies company profile →
SynAgile
HQ: United States
Website
- Description: Provider of DopaFuse, a continuous oral infusion therapy designed to stabilize L-DOPA levels for Parkinson’s disease patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SynAgile company profile →
Oasmia
HQ: Sweden
Website
- Description: Provider of human and veterinary oncology drugs, developing, manufacturing, marketing and selling novel formulations of well-established cytostatics with improved properties, reduced side effects and expanded therapeutic use. Portfolio includes Paccal Vet (XR-17) for canine cancers, Cantrixil for blood cancer, Docetaxel micellar for prostate cancer, and XR-18 delivery technology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oasmia company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Biosensia
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Biosensia
2.2 - Growth funds investing in similar companies to Biosensia
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Biosensia
4.2 - Public trading comparable groups for Biosensia
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →